CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Advanced Breast Cancer Therapies
Breast Cancer Treatment Studies
PARP inhibition in cancer therapy
Publication details
- Journal / source
- Journal of the National Comprehensive Cancer Network
- Volume
- 24
- Issue
- 3.5
- Publication date
- 27 March 2026
- Language
- EN